Stryker (NYSE:SYK – Free Report) had its target price raised by Royal Bank of Canada from $345.00 to $360.00 in a report released on Wednesday morning, Benzinga reports. They currently have an outperform rating on the medical technology company’s stock. A number of other equities analysts also recently weighed in on SYK. Canaccord Genuity Group […]
Related Keywords
Canada , Kevin Lobo , Williame Berry Jr , Prudential Plc , Sequoia Financial Advisors , Morgan Stanley , Stryker Corporation , Fairfield Bush , Canaccord Genuity Group , Royal Bank , Dimensional Fund Advisors , Free Report , Genuity Group , Truist Financial , Moderate Buy , Get Free Report , Fund Advisors , Financial Advisors , Stryker Daily , Stryker , Nyse Syk , Syk , Medical , 86366710 , Boost Price Target , Royal Bank Of Canada ,
vimarsana.com © 2020. All Rights Reserved.